Stock listing

Hamburg:V7B Assembly Biosciences, Inc. Aktie

German listing (Hamburg) of Assembly Biosciences, Inc. · home listing NASDAQ:ASMB

Follow Assembly Biosciences, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:ASMB

$20.09 USD -0.48 (-2.3%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ASMB

Ticker: Hamburg:V7B
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: Hamburg
Currency: EUR

What changed lately

Latest news release · Oct 5, 2026
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 37 slides

Calls

Replays

Assembly Biosciences (NASDAQ:ASMB) Q3 2020 Earnings Call
Thu, Nov 05, 2020 · 5:00 PM ET
Watch Transcript

Latest news

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

Oct 5, 2026

Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference

Sep 10, 2026

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program

Sep 8, 2026

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

Aug 13, 2026

Assembly Biosciences Announces Upcoming Investor Conference Presentations

May 28, 2026

Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

May 26, 2026

Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants

May 22, 2026

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

May 22, 2026

Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026

May 13, 2026

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

May 11, 2026

All Assembly Biosciences, Inc. news

Decks

Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
Technical Presentation (July 2022)
Technical · 55 slides · Jul 26, 2022
AASLD 2019 Review
Conference · 21 slides · Nov 12, 2019
Investor Day (June 2018)
Investor day · 66 slides · Jun 20, 2018

Assembly Biosciences, Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 18 in the last 12 months · 131 in all · newest Oct 5, 2026 · oldest 2019
Calls: 1 call with a replay · 1 with a transcript · latest Nov 5, 2020
Decks: 13 decks · latest September 2026

Where Assembly Biosciences, Inc. is listed

Listing	Exchange	Country	Currency
NASDAQ:ASMB · Home listing	NASDAQ	United States	USD
Tradegate:V7B	Tradegate	Germany	EUR
LS Exchange:A402CB	LS Exchange	Germany	EUR
gettex:V7B	gettex	Germany	EUR
Lang & Schwarz:A402CB	Lang & Schwarz	Germany	EUR
BOATS:ASMB	BOATS	United States	USD
Frankfurt:V7B	Frankfurt	Germany	EUR
Dusseldorf:V7B	Dusseldorf	Germany	EUR
Hamburg:V7B · This page	Hamburg	Germany	EUR
Munich:V7B	Munich	Germany	EUR
Stuttgart:V7B	Stuttgart	Germany	EUR

Log in to ask 6ix AI your own questions about Assembly Biosciences, Inc.